Cell signalling in insulin secretion: the molecular targets of ATP, cAMP and sulfonylurea.

Diabetologia
S Seino

Abstract

Clarification of the molecular mechanisms of insulin secretion is crucial for understanding the pathogenesis and pathophysiology of diabetes and for development of novel therapeutic strategies for the disease. Insulin secretion is regulated by various intracellular signals generated by nutrients and hormonal and neural inputs. In addition, a variety of glucose-lowering drugs including sulfonylureas, glinide-derivatives, and incretin-related drugs such as dipeptidyl peptidase IV (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists are used for glycaemic control by targeting beta cell signalling for improved insulin secretion. There has been a remarkable increase in our understanding of the basis of beta cell signalling over the past two decades following the application of molecular biology, gene technology, electrophysiology and bioimaging to beta cell research. This review discusses cell signalling in insulin secretion, focusing on the molecular targets of ATP, cAMP and sulfonylurea, an essential metabolic signal in glucose-induced insulin secretion (GIIS), a critical signal in the potentiation of GIIS, and the commonly used glucose-lowering drug, respectively.

References

Dec 1, 1985·Pflügers Archiv : European journal of physiology·P Rorsman, G Trube
Jan 1, 1989·Progress in Biophysics and Molecular Biology·F M Ashcroft, P Rorsman
Mar 1, 1989·Diabetes·G C WeirJ F Habener
Oct 1, 1987·Physiological Reviews·M Prentki, F M Matschinsky
Jan 22, 1970·The New England Journal of Medicine·A E Renold
Sep 1, 1968·Endocrinology·D L CurryG M Grodsky
Oct 15, 1984·Experientia·W J Malaisse, F Malaisse-Lagae
Oct 1, 1981·Physiological Reviews·C B Wollheim, G W Sharp
Apr 1, 1980·Physiological Reviews·C J Hedeskov
Apr 1, 1994·The Journal of Clinical Investigation·W P BorgG I Shulman
Apr 5, 1996·The Journal of Biological Chemistry·B ThorensA Porret
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·T MikiS Seino
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·T MikiS Seino
Dec 18, 1998·Science·H KawasakiA M Graybiel
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·N TakahashiH Kasai
Mar 29, 2000·The Journal of Biological Chemistry·V SeghersJ Bryan
Apr 25, 2000·The Journal of Biological Chemistry·J de RooijJ L Bos
Nov 1, 2000·Nature Cell Biology·N OzakiS Seino
Sep 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·W A ChutkowC F Burant
Oct 13, 2001·The Journal of Biological Chemistry·Y KashimaS Seino
Feb 5, 2003·Progress in Biophysics and Molecular Biology·Susumu Seino, Takashi Miki

❮ Previous
Next ❯

Citations

Aug 31, 2012·Science Signaling·Jean-Claude Henquin
Mar 1, 2014·Nature Cell Biology·Bengt-Frederik Belgardt, Markus Stoffel
Nov 23, 2013·Purinergic Signalling·Geoffrey Burnstock
Feb 21, 2014·Journal of Medicinal Chemistry·Thi Tuyet Nhung NguyenDavid Chatenet
Mar 20, 2013·International Journal of Endocrinology·Martin JavorskýIvan Tkáč
Dec 26, 2015·Biochimica Et Biophysica Acta·Ornella LucchesiClaudia N Tomes
Sep 10, 2014·Diabetes, Obesity & Metabolism·T ShibasakiS Seino
Sep 20, 2012·Journal of Diabetes·Zachary Bloomgarden
Feb 18, 2016·Expert Opinion on Investigational Drugs·André J Scheen
Nov 21, 2014·Journal of Diabetes Investigation·Akira KubotaYutaka Seino
Apr 10, 2014·British Journal of Pharmacology·C WestonG Ladds
Apr 29, 2015·Biochemical and Biophysical Research Communications·Shintaro HigashiHitoshi Hashimoto
Nov 1, 2012·Biochemical and Biophysical Research Communications·Abu Saleh Md MoinMasamitsu Nakazato
Jan 23, 2015·The Biochemical Journal·Claudia Nora Tomes
Jun 2, 2015·Biochemical and Biophysical Research Communications·Ewa Gurgul-ConveySigurd Lenzen
Nov 19, 2014·Diabetologia·Matthieu RaouxJochen Lang
Dec 3, 2014·The Medical Clinics of North America·Stephen A Brietzke
May 6, 2016·Annual Review of Nutrition·Katleen LemaireFrans Schuit
May 21, 2017·The American Journal of Medicine·James Thrasher
Dec 7, 2017·Frontiers in Neuroscience·Jiezhong ChenChao Deng
Nov 9, 2018·Journal of Molecular Endocrinology·Quinn DufurrenaRegina Kuliawat
Mar 2, 2019·Angewandte Chemie·Maotong XuDouglas W Stephan
Jul 11, 2019·Chemical Communications : Chem Comm·Xuekun WangXinghai Ning
Mar 19, 2014·The Journal of Biological Chemistry·Sigurd Lenzen
Apr 3, 2014·Physiological Reviews·Ildiko Szabo, Mario Zoratti
May 28, 2019·Endocrine, Metabolic & Immune Disorders Drug Targets·Fatemeh KhatamiSeyed M Tavangar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.